Effect of perioperative continuous infusion of S-ketamine on the quality of postoperative recovery of patients undergoing modified radical mastectomy: a randomized controlled trial

作者
Ke yao Zhang,Yuan Bao,Min Wang,Yi Yang,Wenshan Zhai,Fang Gao
出处
期刊:Research Square 被引量:2
标识
DOI:10.21203/rs.3.rs-1697135/v1
摘要

Abstract Background: Patients undergoing modified radical mastectomy (MRM) often suffer some postoperative adverse events such as acute pain, mental abnormalities, and sleep disorders. This study aim to explore the effect of esketamine as the sole intraoperative analgesic on the quality of postoperative recovery in patients undergoing MRM.Methods: Ninety-eight female patients scheduled for elective MRM were randomly divided into two groups: the esketamine group (group E) or remifentanil group (group R). In group E, anesthesia was induced with etomidate, midazolam, esketamine, and rocuronium, and maintained with intravenous propofol and esketamine. In group R, anesthesia was induced with etomidate, midazolam, rocuronium, and remifentanil, and maintained with propofol and remifentanil. The scores of the Quality of Recovery (QoR-40) questionnaire, and Pittsburgh Sleep Quality Index (PSQI) were evaluated at 1 d, 3 d, 7 d, and 30 d after surgery as primary outcome and main secondary outcome respectively. Other secondary outcomes including intraoperative hemodynamics, postoperative inflammatory indicator, and the incidence of adverse events (e.g., vomiting and dizziness) during hospitalization were also recorded.Main Results: QoR-40 total scores in group E were higher than group R at 1 d [160.71±9.811 VS 146.94±7.375, P<0.001], 3 d [168.45±9.670 VS 152.90±8.089, P<0.001], 7 d [180.06±7.367 VS 175.20±6.334, P=0.001] postoperatively. The PSQI scores in group E were lower than group R at 1 d [14.18±1.740 VS 17.20±1.87, P<0.001], 3 d [11.82±1.799 VS 16.31±2.133, P<0.001], 7 d [7.71±1.814 VS 9.65±1.832, P<0.001] after surgery. Conclusion: Our research shows that esketamine has a certain effect on improving the quality of short-term recovery after MRM.Clinical Trials Registration: Clinical Trials gov: ChiCTR2200056576. registered February 8th, 2022, http://www.chictr.org.cn/index.aspx.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
华仔的应助被Yu采纳,获得10
3秒前
乐观乐枫发布了新的文献求助10
3秒前
lonely63315发布了新的文献求助10
3秒前
3秒前
SciGPT的应助被11采纳,获得10
3秒前
完美访烟完成签到,获得积分10
3秒前
ding的应助被整齐听南采纳,获得10
3秒前
怡然的幻灵完成签到,获得积分10
4秒前
科研通AI6.2的应助被Sunnig盈采纳,获得10
4秒前
科研通AI6.4的应助被pcx采纳,获得10
4秒前
nuodei完成签到 ,获得积分10
5秒前
慕青的应助被迷路的翠容采纳,获得10
5秒前
饱满板栗完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
bhsadhusu发布了新的文献求助20
6秒前
小Ha发布了新的文献求助50
6秒前
无敌哼哼发布了新的文献求助10
6秒前
上官若男的应助被zyh采纳,获得10
6秒前
羊羊发布了新的文献求助10
6秒前
7秒前
zhaosh完成签到,获得积分10
7秒前
9秒前
桐桐的应助被蔡俞隆采纳,获得10
9秒前
传奇3的应助被科研达人采纳,获得10
9秒前
10秒前
金克丝发布了新的文献求助10
11秒前
11完成签到,获得积分10
11秒前
ding的应助被不辣的皮特采纳,获得10
11秒前
科研通AI6.2的应助被lonely63315采纳,获得10
12秒前
12秒前
尊嘟假嘟的应助被KerwinLLL采纳,获得30
13秒前
13秒前
KKK613完成签到,获得积分10
14秒前
14秒前
Hello的应助被redpanda1103采纳,获得10
14秒前
尹梦成完成签到,获得积分10
14秒前
李健的小迷弟的应助被wu采纳,获得30
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Spec 401: Standards for Jet Fuel Facility and Equipment Commissioning and Flushing at Airports, 2026.1 (Original Issue) 1000
Spec 103: Standard for Jet Fuel Quality Control at Airports, Revision 2026.1 1000
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Introduction to Industrial/Organizational Psychology 800
Topological Photonics: Fundamentals and Applications 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8093173
求助须知:如何正确求助?哪些是违规求助? 9505330
关于积分的说明 21446822
捐赠科研通 7666483
什么是DOI,文献DOI怎么找? 3405552
关于科研通互助平台的介绍 2533782
邀请新用户注册赠送积分活动 2444598